Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending July 1
McDonald’s, Dollar Tree, GoFundMe, Stride, Otis, Intrusion, Monogram Health, Mass Luminosity
By
Lauren Muskett
| July 1, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Ian Read
Financial Performance
Pfizer Beats Estimates on Strength in Key Drugs
Sales from Pfizer's innovative health division were particularly strong in the second quarter, with anti-smoking drug Chantix up 8% to $8.2 billion.
By
Matthew Heller
| July 31, 2018
Read More
Financial Performance
Generic Competition Hits Pfizer’s Q2 Sales
The drug maker cites headwinds from losses of market exclusivity for the 14% drop in Essential Health revenues.
By
Matthew Heller
| August 2, 2017
Read More